Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Champion

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2017
Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imagingPaolo Zanotti-Fregonara, Clément Morgat, Christophe Champion, et al.
Lancet (London, England)|August 8, 2021
Targeted radioactive therapy for prostate cancerElif Hindié, Clément Morgat, Mario E Alcocer-Ávila, et al.
Scientific Reports|July 19, 2017
Differential electron emission from polycyclic aromatic hydrocarbon molecules under fast ion impactShubhadeep Biswas, Christophe Champion, P F Weck, et al.
Scientific Reports|December 6, 2017
Author Correction: Differential electron emission from polycyclic aromatic hydrocarbon molecules under fast ion impactShubhadeep Biswas, Christophe Champion, P F Weck, et al.
EJNMMI Physics|November 21, 2024
Comparative analysis of positron emitters for theranostic applications based on small bioconjugates highlighting <sup>43</sup>Sc, <sup>61</sup>Cu and <sup>45</sup>TiElif Hindié, Ulli Köster, Christophe Champion, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 15, 2023
Membrane and Nuclear Absorbed Doses from <sup>177</sup>Lu and <sup>161</sup>Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting-A Monte Carlo StudyAlexandre Larouze, Mario Alcocer-Ávila, Clément Morgat, et al.
The Journal of Chemical Physics|May 2, 2016
Experimental and theoretical double differential cross sections for electron impact ionization of methaneMurat Yavuz, Zehra Nur Ozer, Melike Ulu, et al.
Theranostics|August 8, 2024
Palladium-103 (<sup>103</sup>Pd/<sup>103m</sup>Rh), a promising Auger-electron emitter for targeted radionuclide therapy of disseminated tumor cells - absorbed doses in single cells and clusters, with comparison to <sup>177</sup>Lu and <sup>161</sup>TbElif Hindié, Alexandre Larouze, Mario Alcocer-Ávila, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 2016
Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical TherapyElif Hindié, Paolo Zanotti-Fregonara, Michele A Quinto, et al.
Theranostics|July 23, 2016
Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual DiseaseChristophe Champion, Michele A Quinto, Clément Morgat, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2017
Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imagingPaolo Zanotti-Fregonara, Clément Morgat, Christophe Champion, et al.
Lancet (London, England)|August 8, 2021
Targeted radioactive therapy for prostate cancerElif Hindié, Clément Morgat, Mario E Alcocer-Ávila, et al.
Scientific Reports|July 19, 2017
Differential electron emission from polycyclic aromatic hydrocarbon molecules under fast ion impactShubhadeep Biswas, Christophe Champion, P F Weck, et al.
Scientific Reports|December 6, 2017
Author Correction: Differential electron emission from polycyclic aromatic hydrocarbon molecules under fast ion impactShubhadeep Biswas, Christophe Champion, P F Weck, et al.
EJNMMI Physics|November 21, 2024
Comparative analysis of positron emitters for theranostic applications based on small bioconjugates highlighting <sup>43</sup>Sc, <sup>61</sup>Cu and <sup>45</sup>TiElif Hindié, Ulli Köster, Christophe Champion, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 15, 2023
Membrane and Nuclear Absorbed Doses from <sup>177</sup>Lu and <sup>161</sup>Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting-A Monte Carlo StudyAlexandre Larouze, Mario Alcocer-Ávila, Clément Morgat, et al.
The Journal of Chemical Physics|May 2, 2016
Experimental and theoretical double differential cross sections for electron impact ionization of methaneMurat Yavuz, Zehra Nur Ozer, Melike Ulu, et al.
Theranostics|August 8, 2024
Palladium-103 (<sup>103</sup>Pd/<sup>103m</sup>Rh), a promising Auger-electron emitter for targeted radionuclide therapy of disseminated tumor cells - absorbed doses in single cells and clusters, with comparison to <sup>177</sup>Lu and <sup>161</sup>TbElif Hindié, Alexandre Larouze, Mario Alcocer-Ávila, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 2016
Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical TherapyElif Hindié, Paolo Zanotti-Fregonara, Michele A Quinto, et al.
Theranostics|July 23, 2016
Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual DiseaseChristophe Champion, Michele A Quinto, Clément Morgat, et al.
Pageof 4